Johnson & Johnson Pharmaceutical Research & Development, L.L.C., (J&JPRD) announced that it has submitted a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for doripenem, an investigational carbapenem antibiotic for the treatment of nosocomial pneumonia, a pneumonia that is acquired in a hospital or other healthcare setting.
The G8 leaders promised an increase in investment in programs to fight AIDS, tuberculosis, and malaria, but the $60 billion total will still be only one-third of what the UN says is needed over the next five years. Together, these diseases kill about 16,000 people each day.
A childhood sleep-related breathing disorder (SRBD) is known to have negative consequences on cognitive development, behavior, quality of life and utilization of health care resources. However, a research abstract that will be presentedMonday at SLEEP 2007, the 21st Annual Meeting of the Associated Professional Sleep Societies (APSS), finds that breastfeeding may provide long-term protection against the incidence or severity of a childhood SRBD.
Schering-Plough Corporation (NYSE: SGP) and Bayer HealthCare today announced that ZETIA(R) (ezetimibe), a novel cholesterol-lowering agent that inhibits the absorption of cholesterol in the intestine, is now available in Japan for use in patients with hypercholesterolemia, familial hypercholesterolemia or homozygous sitosterolemia.
For many patients, a visit to the primary care physician tends to be a one-sided conversation. Patients begin by stating one medical problem, and immediately the doctor takes over.
Two new studies find the uninsured and people with certain types of public health insurance are more likely to be diagnosed with more advanced cancer compared to those with private insurance.
Nearly half of all patients are currently being treated within 18 weeks, a year and a half ahead of schedule, according to the first official figures produced by the Department of Health today.
The Medicines and Healthcare Products Regulatory Agency is investigating false negative results in one lot of Clearview HCG pregnancy test kits (lot HG0050). The affected lot was distributed to UK hospitals between March and April this year.
CIGNA HealthCare announced that it has signed contracts with three major Washington providers, Swedish Medical Center, MultiCare Health System and Providence Health System.
Health Protection Agency HPA, UK confirms that a review of patients’ case notes in hospitals across England and Scotland has been carried out.